XII Medical: $45 Million (Series B) Raised To Develop Therapies For Obstructive Sleep Apnea

Retrieved on: 2024-08-21 20:06:34

Tags for this article:

Click the tags to see associated articles and topics

XII Medical: $45 Million (Series B) Raised To Develop Therapies For Obstructive Sleep Apnea. View article details on hiswai:

Excerpt

XII Medical, a clinical-stage medical technology company developing innovative therapies for obstructive sleep apnea, announced the closing of a ...

Article found on: pulse2.com